The role of an independent statistical analysis center in the Industry-Modified National Institutes of Health Model

Drug Information Journal

Volumn 35, Issue 1, 2001, Pages 115-129

  Fisher, M R ^a   Roecker, E B ^a   DeMets, D L ^a  

^a Departments of Biostatistics and Medical Informatics   (United States)

Author keywords

Data and safety monitoring; Industry modified NIH model; NIH model; Organizational structure; Randomized clinical trial

Indexed keywords

CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG INDUSTRY; DRUG INFORMATION; DRUG MONITORING; DRUG RESEARCH; HEALTH CARE ORGANIZATION; MANAGEMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; STATISTICAL ANALYSIS;

EID: 0035092538     PISSN: 00928615     EISSN: None     Source Type: Journal    
DOI: 10.1177/009286150103500113     Document Type: Review

References (23)

1. Organization, review and administration of cooperative studies (Greenberg Report): A report from the heart special project committee to the National Advisory Council, May 1967
2. The NHLB1 model: A 25 year history
3. International Conference on Harmonisation. E9 Statistical Principles for Clinical Trials
4. Patients and Methods
5. Effect of oral milrinone on mortality in severe chronic heart failure
6. Effect of amlodipine on morbidity and mortality of in severe cronic heart failure
7. Randomized double-blind trial of fixed low dose warfarin with aspirin after myocardial infarction
8. A dose-dependent increase in mortality with Vesnarinone among patients with severe heart failure
9. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF)
10. Long-term treatment with a platelet glycoprotein-receptor antagonist after percutaneous coronary revascularization
11. Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock
12. Proceedings of "Practical Issues in Data Monitoring of Clinical Trials," Bethesda, Maryland, U.S.A., January 27-28, 1992
13. Monitoring of clinical trials: Issues and recommendations
14. The Data and Safety Monitoring Board and Acquired Immune Deficiency Syndrome (AIDS) clinical trials
15. Data and Safety Monitoring Boards
16. Principles of Data and Safety Monitoring Boards
17. Sequential monitoring of multiple endpoints in clinical trials
18. Data monitoring committees for multicenter clinical trails sponsored by the National Institutes of Health. I: Roles and membership of data monitoring committees sponsored by the National Eye Institute
19. Clinical trials and treatment effects monitoring, comments and rejoinder
20. The use of external monitoring committees in clinical trials of the national institute of allergy and infectious diseases
21. Biomedical research and insider trading